Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 May 5:15:133-142.
doi: 10.2147/BTT.S252574. eCollection 2021.

Biological Therapies in Children and Adolescents with Severe Uncontrolled Asthma: A Practical Review

Martina Votto #  1   2 , Maria De Filippo #  1   2 , Amelia Licari  1   2 , Alessia Marseglia  2 , Mara De Amici  3 , Gian Luigi Marseglia  1   2
Affiliations
Review

Biological Therapies in Children and Adolescents with Severe Uncontrolled Asthma: A Practical Review

Martina Votto et al. Biologics. .

Abstract

Severe uncontrolled asthma is a complex and heterogeneous disease. A multidisciplinary assessment is required to correctly identify and manage children and adolescents with severe asthma because they may require strict monitoring and additional treatment with advanced targeted therapies. Recent research efforts have focused on identifying epidemiologic, clinical, and molecular mechanisms that underlie severe asthma, leading to the recognition of different phenotypes and endotypes and identifying biomarkers able to predict the response to biologic therapies. Additional progress has occurred by introducing biological therapies that have revolutionized the care of chronic allergic diseases in the adult and pediatric population. In this review, we briefly summarized the current literature on biological therapies to treat severe asthma in children and adolescents.

Keywords: adolescents; biological therapy; children; endotype; phenotype; severe asthma.

PubMed Disclaimer

Conflict of interest statement

The authors report no conflicts of interest in this work.

References

    1. Sánchez-Borges M, Martin BL, Muraro AM, et al. The importance of allergic disease in public health: an iCAALL statement. World Allergy Organ J. 2018;11(1):8. doi:10.1186/s40413-018-0187-2 - DOI - PMC - PubMed
    1. Licari A, Manti S, Marseglia A, et al. Biologics in children with allergic diseases. Curr Pediatr Rev. 2020;16(2):140–147. doi:10.2174/1573396315666191029123822 - DOI - PubMed
    1. Licari A, Ciprandi R, Marseglia G, et al. Anxiety and depression in adolescents with severe asthma and in their parents: preliminary results after 1 year of treatment. Behav Sci (Basel). 2019;9(7):78. doi:10.3390/bs9070078 - DOI - PMC - PubMed
    1. Licari A, Ciprandi R, Marseglia G, et al. Anxiety and depression in adolescents with asthma and in their parents: a study in clinical practice. Monaldi Arch Chest Dis. 2019;89(3):3. doi:10.4081/monaldi.2019.1063 - DOI - PubMed
    1. Licari A, Ciprandi R, Marseglia G, et al. Anxiety/depression changes are associated with improved asthma control perception in asthmatic adolescents after adequate management. Eur Ann Allergy Clin Immunol. 2019;51(4):190–192. doi:10.23822/EurAnnACI.1764-1489.97 - DOI - PubMed